GlucoTrack Stock Surges 103805 Percent in Trading Volume Ranking 363rd in Daily Market

On June 25, 2025, GlucoTrack (GCTK) experienced a significant surge, with its trading volume reaching 2.69 billion, marking a 103805.25% increase from the previous day. This surge placed GlucoTrack at the 363rd position in the daily stock market rankings. The stock price of GlucoTrack rose by 26.25%.

GlucoTrack's stock price soared on Wednesday following the presentation of clinical trial results at the American Diabetes Association’s 85th Scientific Sessions. The trial focused on the company's innovative blood-based continuous glucose monitoring technology, marking the first human trial of the diabetes monitoring device. The clinical trial successfully met all its primary and secondary endpoints, including a Mean Absolute Relative Difference of 7.7%, a 99% data capture rate, and no procedure or device-related serious adverse events. The company plans to initiate a long-term early feasibility study of the device in the third quarter of 2025.

These positive clinical trial results garnered significant attention from traders, driving the stock's upward momentum. The company's stock has faced a challenging year, with a year-to-date decline of 96.8% and a 12-month drop of 99.75%. However, the recent surge in trading volume, with 1.33 million shares changing hands compared to a three-month daily average of 75,160 units, indicates renewed investor interest.